Congenital adrenal hyperplasia

Archivio Italiano di Urologia e Andrologia

Volumn 76, Issue 3, 2004, Pages 143-146

  Spandri, Angela ^a   Cogliardi, Anna ^a   Maggi, Paola ^a   De Giorgi, Anna ^a   Masperi, Rita ^a   Beccaria, Luciano ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

Adrenal glands; Congenital adrenal hyperplasia; Endocrinology

Indexed keywords

GLUCOCORTICOID; HYDROXYPROGESTERONE; STEROID 21 MONOOXYGENASE;

ADRENAL CORTEX INSUFFICIENCY; ADRENAL INSUFFICIENCY; CHROMOSOME 6; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; CORTICOTROPIN TEST; CYP21 GENE; GENE; GENE MUTATION; HUMAN; HYPERANDROGENISM; PRECOCIOUS PUBERTY; SALT LOSING NEPHRITIS; STEROID 21 MONOOXYGENASE DEFICIENCY; VIRILIZATION;

ADRENAL HYPERPLASIA, CONGENITAL; HUMANS;

EID: 8144227390     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. White PC, New MI, Dupont B. Congenital adrenal hyperplasia. N Engl J Med 1987; 316:1519
2. Pang S. Congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 1997; 26:853
3. Speiser PW, White PC. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 1998; 49:411
4. Speiser PW, White PCW. Congenital adrenal hyperplasia. N Engl J Med 2003; 349:776
5. New MI. Diagnosis and management of Congenital Adrenal Hyperplasia. Ann Rev Med 1998; 49:311
6. Miller W. The adrenal cortex and its disorders. In: CDB Brooks, PCHindmarsh (Eds) Clinical Pediatric Endocrinology. 4th ed. Blackwell Science, 2001; 321
7. Stewart PM. The Adrenal Cortex. In, Larsen, Kronenberg, Melmed, Polonsky (Eds), Williams Textbook of Endocrinology. 10th eds Philadelphia: Saunders 2003; 532
8. New MI, White P, Pang S, Dupont P, Speiser PW. The adrenal hyperplasia. In: CR Scriver, A Beaudet, S Sly, Volle D (eds), The molecular basis of Inherited disease. New York: McGraw-Hill, 1989; 1881
9. Miller WL, Levine LS. Molecular and clinical advances in congenital adrenal hyperplasia. J Pediatr 1987; 111:1
10. Scaroni C, Opocher G, Mantero F. Renin-angiotensin-aldosterone system: a long term follow-up study in 17a-hydroxylase deficiency syndrome. Hypertension 1986; A8:773
11. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-OH hydroxylase deficiency. Endocr Rev 2000; 21:245
12. Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW. Consensus Statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and The European Society for Pediatric Endocrinology. J Clin Endocrinol Metab 2002; 87:4048
13. Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW. Consensus statement on 21-hydroxylase deficiency from the European Society for Pediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002; 58:188
14. Migeon CJ, Rosenwask Z, Lee PA, Urban MD, Bias WB. The attenuated form of congenital adrenal hyperplasias an allelic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1980; 51:647
15. Panitsa-Faflia C, Batrinos ML. Late-onset congenital adrenal hyperplasia. Ann N Y Acad Sci 1997; 17:816
16. Pang S, Wallace MA, Hofman L, et al. Worldwide experience in newborn screening for classical congenital hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 81:866
17. Therrell BL Jr, Berenbaum SA, Manter-Kapanke V, et al. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 1998; 101:583
18. Sherman SL, Aston CE, Morton NE, Speriser PW, New MI. A segregation and linkage study of classical and non-classical 21-hydroxylase deficiency. Am J Hum Genet 1988; 42:830
19. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37:650
20. Fiet J, Gueux B, Gourmelen M, et al. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17- hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia. J Clin Endocrinol Metab 1988; 66:659
21. New MI, Lorenzen F, Lerner AJ, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983, 57:320
22. Dickstein G, Shechner C, Nicholson WE, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991; 72:773
23. Lashansky G, Saenger P, Fishman K, et al. Normative data for adrenal steroidogenesis in a healthy pediatric population: age and sex-related changes after ACTH stimulation. J Clin Endocrinol Metab 1991; 73:674
24. Zarkovic M, Ciric J, Stojanovic M, et al. Optimizing the diagnostic criteria for standard (250-microg) and low dose (1-microg) adrenocorticotropin tests in the assessment of adrenal function. J Clin Endocrinol Metab 1999; 84:3170
25. Bode HH, Rivkees SA, Cowley DM, Pardy K, Johnson S. Home monitoring of 17 hydroxyprogesterone levels in congenitx127drenal hyperplasia with filter paper blood samples. J Pediatr 1999; 134:185
26. Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA 1986; 83:2841
27. White PC, Vitek A, Dupont B, New MI. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 1988; 85:4436
28. Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 1995; 80:2322
29. Day DJ, Speiser PW, White PC, Barany F. Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction. Genomics 1995; 29:152
30. Wedell A. Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment. Acta Paediatr 1998; 87:159
31. Collett-Solberg PF. Congenital adrenal hyperplasia: from genetics and biochemistry to clinical practice, part 2. Clin Pediatr (Philadelphia). 2001; 40:125
32. Deneux C, Tardy V, Dib A, et al. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2001; 86:207
33. Kovacs J, Votava F, Heinze G, et al. Middle European Workshop on Paediatric Endocrinology-Congenital Adrenal Hyperplasia Study Group. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J Clin Endocrinol Metab 2001; 86:2958
34. Speiser PW. Congenital adrenal hyperplasia: transition from childhood to adulthood. J Endocrinol Invest 2001; 24:681
35. Schnitzer JJ, Donahoe PK. Surgical treatment of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30:137
36. Creighton SM, Minto CL, Steele SJ. Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. Lancet 2001; 358:124
37. Schwartz RP. Bach to basics: early diagnosis and compliance improve final height outcome in congenital adrenal hyperplasia. J Pediatr 2001; 138:3
38. Eugster EA, Dimeglio LA, Wright JC, et al. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr 2001; 138:26
39. Jaaskelainen J, Voutilainen R. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatr Res 1997; 41:30
40. Yu AC, Grant DB. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood. Acta Paediatr 1995; 84:899
41. Premawardhana LD, Hughes IA, Read GF, Scanlon MF. Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin Endocrinol (Oxf) 1997; 46:327
42. Urban MD, Lee PA, Migeon CJ. Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N Engl J Med 1978; 299:1392
43. Cabrera MS, Vogiatzi MG, New MI. Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86:3070
44. Migeon CJ, Wisniewski AB. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency: growth, development, and therapeutic considerations. Endocrinol Metab Clin North Am 2001; 30:193
45. New MI, Carlson A, Obeid J, et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 2001; 86:5651
46. Pang SY, Pollack MS, Marshall RN, Immken L. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1990; 322:111
47. Seckl JR, Miller WL. How safe is long-term prenatal glucocorticoid treatment? JAMA 1997; 277:1077
48. Newnham JP. Is prenatal glucocorticoid administration another origin of adult disease? Clin Exp Pharmacol Physiol 2001; 28:957
49. Pang S, Clark AT, Freeman LC, et al. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. J Clin Endocrinol Metab 1992; 75:249